These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15228070)

  • 1. Thrombotic complications at altitude.
    Zafren K
    Wilderness Environ Med; 2004; 15(2):155. PubMed ID: 15228070
    [No Abstract]   [Full Text] [Related]  

  • 2. Thromboembolism prevention in ischaemic stroke.
    O'Donnell M; Kearon C
    Lancet; 2007 Apr; 369(9571):1413-1415. PubMed ID: 17467497
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence-based evaluation of preoperative vs postoperative use of low-molecular-weight heparin in preventing deep vein thrombosis in elective hip surgery.
    Ghosh A
    Arch Intern Med; 1999 Jul; 159(14):1622-3. PubMed ID: 10421287
    [No Abstract]   [Full Text] [Related]  

  • 4. Summaries for patients. Low-molecular-weight heparin given for several weeks after hip surgery prevents deep venous thrombosis.
    Ann Intern Med; 2001 Nov; 135(10):S-55. PubMed ID: 11757493
    [No Abstract]   [Full Text] [Related]  

  • 5. Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants.
    DeLoughery TG
    Crit Care Clin; 2005 Jul; 21(3):497-512. PubMed ID: 15992670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of venous thromboembolism after acute ischaemic stroke.
    Ricci S; Celani MG; Righetti E; Dennis M; Sandercock P
    Lancet; 2007 Sep; 370(9589):735-6; author reply 736-7. PubMed ID: 17765511
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of LMW heparin: information for prescribers. Update: 10 April 2002].
    Agence Française de Sécurité Sanitaire Des Produits de Santé (AFSSAPS)
    J Mal Vasc; 2002 Oct; 27(4):231-3. PubMed ID: 12457130
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-molecular-weight heparin for treating venous thromboembolism.
    Mahoney MS; Kahn M
    Ann Intern Med; 1999 Jan; 130(1):77-8. PubMed ID: 9890863
    [No Abstract]   [Full Text] [Related]  

  • 9. Low molecular weight heparins: are they interchangeable? No.
    Nenci GG
    J Thromb Haemost; 2003 Jan; 1(1):12-3. PubMed ID: 12871532
    [No Abstract]   [Full Text] [Related]  

  • 10. Low-molecular-weight heparins for the prevention and treatment of venous thromboembolism.
    Ornstein DL; Hong-Dice YG; Papini JR
    Mil Med; 2001 Jul; 166(7):593-601. PubMed ID: 11469031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism: a guide to prevention and treatment.
    Crowther M; McCourt K
    Nurse Pract; 2005 Aug; 30(8):26-9, 32-4, 39-43; quiz 44-5. PubMed ID: 16094200
    [No Abstract]   [Full Text] [Related]  

  • 12. [What are the safety measures for use of low-molecular-weight heparins in the treatment of deep venus thrombosis?].
    Fiessinger JN
    Presse Med; 2000 Apr; 29(13):766-8. PubMed ID: 10797834
    [No Abstract]   [Full Text] [Related]  

  • 13. Preventing venous thromboembolism in the intensive care unit: A no-brainer?
    Gould MK
    J Crit Care; 2005 Dec; 20(4):304-5. PubMed ID: 16310598
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evidence for thrombosis prophylaxis to high-risk patients].
    Själander A; Jansson JH; Bergqvist D; Eriksson H; Svensson P
    Lakartidningen; 2007 May 14-29; 104(20-21):1585-7. PubMed ID: 17564265
    [No Abstract]   [Full Text] [Related]  

  • 15. Venous thromboembolism and pregnancy.
    Andres RL; Miles A
    Obstet Gynecol Clin North Am; 2001 Sep; 28(3):613-30. PubMed ID: 11512505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Venous thromboprophylaxis postcaesarean: survey of practices in Lorraine].
    Vial F; Hein F; Boileau S; Vedel M; Bouaziz H
    Ann Fr Anesth Reanim; 2009 Apr; 28(4):395-6. PubMed ID: 19303734
    [No Abstract]   [Full Text] [Related]  

  • 17. Deep venous thrombosis: outpatient therapy with low-molecular-weight heparin.
    Tapson VF
    Manag Care; 1999 Dec; 8 Suppl():2-6. PubMed ID: 11729399
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of deep vein thrombosis. First choice treatments.
    Prescrire Int; 2015 Sep; 24(163):217-9. PubMed ID: 26417635
    [No Abstract]   [Full Text] [Related]  

  • 19. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety.
    Hirsh J; Warkentin TE; Shaughnessy SG; Anand SS; Halperin JL; Raschke R; Granger C; Ohman EM; Dalen JE
    Chest; 2001 Jan; 119(1 Suppl):64S-94S. PubMed ID: 11157643
    [No Abstract]   [Full Text] [Related]  

  • 20. An open-label comparison of the efficacy and safety of certoparin versus unfractionated heparin for the prevention of thromboembolic complications in acutely ill medical patients: CERTAIN.
    Schellong SM; Haas S; Greinacher A; Schwanebeck U; Sieder C; Abletshauser C; Bramlage P; Riess H
    Expert Opin Pharmacother; 2010 Dec; 11(18):2953-61. PubMed ID: 20950224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.